These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25118787)

  • 1. A monoclonal antibody against PMEL.
    Shi F; Xu Z; Chen H; Wang X; Cui J; Zhang P; Zhang P; Xie X
    Monoclon Antib Immunodiagn Immunother; 2014 Oct; 33(5):354-60. PubMed ID: 25118787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression cloning of the cDNA encoding a melanoma-associated Ag recognized by mAb HMB-45. Identification as melanocyte-specific Pmel 17 cDNA.
    Wagner SN; Wagner C; Höfler H; Atkinson MJ; Goos M
    Lab Invest; 1995 Aug; 73(2):229-35. PubMed ID: 7637323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody against GPNMB.
    Zhang P; Li J; Pang X; Yuan X; Li D; Li Y; Guo L; Liu W
    Monoclon Antib Immunodiagn Immunother; 2013 Aug; 32(4):265-9. PubMed ID: 23909420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100.
    Skipper JC; Kittlesen DJ; Hendrickson RC; Deacon DD; Harthun NL; Wagner SN; Hunt DF; Engelhard VH; Slingluff CL
    J Immunol; 1996 Dec; 157(11):5027-33. PubMed ID: 8943411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
    Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PKD domain distinguishes the trafficking and amyloidogenic properties of the pigment cell protein PMEL and its homologue GPNMB.
    Theos AC; Watt B; Harper DC; Janczura KJ; Theos SC; Herman KE; Marks MS
    Pigment Cell Melanoma Res; 2013 Jul; 26(4):470-86. PubMed ID: 23452376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigen.
    Rochaix P; Lacroix-Triki M; Lamant L; Pichereaux C; Valmary S; Puente E; Al Saati T; Monsarrat B; Susini C; Buscail L; Delsol G; Voigt JJ
    Mod Pathol; 2003 May; 16(5):481-90. PubMed ID: 12748255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of the melanocyte lineage-specific antigen gp100.
    Adema GJ; de Boer AJ; Vogel AM; Loenen WA; Figdor CG
    J Biol Chem; 1994 Aug; 269(31):20126-33. PubMed ID: 7519602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCB6 Resides in Melanosomes and Regulates Early Steps of Melanogenesis Required for PMEL Amyloid Matrix Formation.
    Bergam P; Reisecker JM; Rakvács Z; Kucsma N; Raposo G; Szakacs G; van Niel G
    J Mol Biol; 2018 Oct; 430(20):3802-3818. PubMed ID: 29940187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The silver locus product (Silv/gp100/Pmel17) as a new tool for the analysis of melanosome transfer in human melanocyte-keratinocyte co-culture.
    Singh SK; Nizard C; Kurfurst R; Bonte F; Schnebert S; Tobin DJ
    Exp Dermatol; 2008 May; 17(5):418-26. PubMed ID: 18331332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of Pmel alters melanosome shape but has only a subtle effect on visible pigmentation.
    Hellström AR; Watt B; Fard SS; Tenza D; Mannström P; Narfström K; Ekesten B; Ito S; Wakamatsu K; Larsson J; Ulfendahl M; Kullander K; Raposo G; Kerje S; Hallböök F; Marks MS; Andersson L
    PLoS Genet; 2011 Sep; 7(9):e1002285. PubMed ID: 21949658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of serum autoantibodies against premelanosome protein 17 increases in the vitiligo patients].
    Hu L; Sun L; Li Y; Li H; Liang D; Sun J; Wang X; Hu J; Xie X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Apr; 29(4):411-3, 417. PubMed ID: 23643172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The melanosomal protein PMEL17 as a target for antibody drug conjugate therapy in melanoma.
    Chen Y; Chalouni C; Tan C; Clark R; Venook R; Ohri R; Raab H; Firestein R; Mallet W; Polakis P
    J Biol Chem; 2012 Jul; 287(29):24082-91. PubMed ID: 22613716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.
    Tse KF; Jeffers M; Pollack VA; McCabe DA; Shadish ML; Khramtsov NV; Hackett CS; Shenoy SG; Kuang B; Boldog FL; MacDougall JR; Rastelli L; Herrmann J; Gallo M; Gazit-Bornstein G; Senter PD; Meyer DL; Lichenstein HS; LaRochelle WJ
    Clin Cancer Res; 2006 Feb; 12(4):1373-82. PubMed ID: 16489096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines.
    Hertzman Johansson C; Azimi A; Frostvik Stolt M; Shojaee S; Wiberg H; Grafström E; Hansson J; Egyházi Brage S
    Melanoma Res; 2013 Oct; 23(5):360-5. PubMed ID: 23921446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A melanocyte-specific complementary DNA clone whose expression is inducible by melanotropin and isobutylmethyl xanthine.
    Kwon BS; Halaban R; Kim GS; Usack L; Pomerantz S; Haq AK
    Mol Biol Med; 1987 Dec; 4(6):339-55. PubMed ID: 2449595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of mouse monoclonal antibodies reactive with chicken CD83.
    Lee SH; Lillehoj HS; Jang SI; Lee KW; Baldwin C; Tompkins D; Wagner B; Del Cacho E; Lillehoj EP; Hong YH
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):527-33. PubMed ID: 22197010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PMEL Amyloid Fibril Formation: The Bright Steps of Pigmentation.
    Bissig C; Rochin L; van Niel G
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
    Kuan CT; Wakiya K; Dowell JM; Herndon JE; Reardon DA; Graner MW; Riggins GJ; Wikstrand CJ; Bigner DD
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1970-82. PubMed ID: 16609006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Domains and Evolutionary History of the PMEL and GPNMB Family Proteins.
    Chrystal PW; Footz T; Hodges ED; Jensen JA; Walter MA; Allison WT
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34207849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.